Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5988461 | 1.00 | CYP1A1 (0.33) | CYP1A1CYP1A2CYP1B1ALK | |
| SCHEMBL26259876 | 0.86 | CYP1A2 (0.38) | CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL497590 | 0.83 | CYP1A1 (0.45) | CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL26259740 | 0.81 | CYP1A2 (0.46) | CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL12278231 | 0.81 | CYP1A1 (0.39) | CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL5989852 | 0.81 | CYP1A1 (0.36) | CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL12260023 | 0.80 | CYP1A1 (0.47) | CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL12278119 | 0.80 | CYP1A1 (0.47) | CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL12405231 | 0.80 | CYP1A1 (0.47) | CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL5989327 | 0.79 | CYP1A1 (0.32) | CYP1A1CYP1A2CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060267004-A1 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | UNIVERSITY OF OTTAWA (CA) | 2006-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060267004-A1 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | JUP, LATS2, CDH1 | CYP1A1 2576/4885CYP1A2 1807/4885CYP1B1 1021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.